BR112018073642A2 - toe imaging immunomodulators - Google Patents
toe imaging immunomodulatorsInfo
- Publication number
- BR112018073642A2 BR112018073642A2 BR112018073642-2A BR112018073642A BR112018073642A2 BR 112018073642 A2 BR112018073642 A2 BR 112018073642A2 BR 112018073642 A BR112018073642 A BR 112018073642A BR 112018073642 A2 BR112018073642 A2 BR 112018073642A2
- Authority
- BR
- Brazil
- Prior art keywords
- immunomodulators
- imaging
- toe
- toe imaging
- milamolecules
- Prior art date
Links
- 238000003384 imaging method Methods 0.000 title abstract 2
- 239000002955 immunomodulating agent Substances 0.000 title 1
- 229940121354 immunomodulator Drugs 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/03—Computed tomography [CT]
- A61B6/037—Emission tomography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/12—Arrangements for detecting or locating foreign bodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Surgery (AREA)
- Radiology & Medical Imaging (AREA)
- Pathology (AREA)
- High Energy & Nuclear Physics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
a presente invenção refere-se à síntese e uso de milamoléculas marcadas com 18f para realizar imagiologia de vários processos que ocorrem no interior do corpo, para detectar o local de moléculas associadas a patologia de doença e monitorar o progresso da doença.The present invention relates to the synthesis and use of 18f-labeled milamolecules to perform imaging of various processes occurring within the body, to detect the location of disease pathology-associated molecules and to monitor disease progress.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662338872P | 2016-05-19 | 2016-05-19 | |
US62/338,872 | 2016-05-19 | ||
PCT/US2017/033004 WO2017201111A1 (en) | 2016-05-19 | 2017-05-17 | Pet-imaging immunomodulators |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112018073642A2 true BR112018073642A2 (en) | 2019-02-26 |
Family
ID=59021563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112018073642-2A BR112018073642A2 (en) | 2016-05-19 | 2017-05-17 | toe imaging immunomodulators |
Country Status (24)
Country | Link |
---|---|
US (2) | US11103605B2 (en) |
EP (2) | EP3458111B1 (en) |
JP (1) | JP6953444B2 (en) |
KR (1) | KR102378288B1 (en) |
CN (1) | CN109414514B (en) |
AU (1) | AU2017268291B2 (en) |
BR (1) | BR112018073642A2 (en) |
CA (1) | CA3024844A1 (en) |
CY (1) | CY1124241T1 (en) |
DK (1) | DK3458111T3 (en) |
EA (1) | EA038019B1 (en) |
ES (1) | ES2864091T3 (en) |
HR (1) | HRP20210644T8 (en) |
HU (1) | HUE054306T2 (en) |
IL (1) | IL262962B (en) |
LT (1) | LT3458111T (en) |
MA (1) | MA53402A (en) |
MX (1) | MX2018014028A (en) |
PL (1) | PL3458111T3 (en) |
PT (1) | PT3458111T (en) |
RS (1) | RS61742B1 (en) |
SG (1) | SG11201810177VA (en) |
SI (1) | SI3458111T1 (en) |
WO (1) | WO2017201111A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9856292B2 (en) | 2014-11-14 | 2018-01-02 | Bristol-Myers Squibb Company | Immunomodulators |
US10143746B2 (en) | 2016-03-04 | 2018-12-04 | Bristol-Myers Squibb Company | Immunomodulators |
US10358463B2 (en) | 2016-04-05 | 2019-07-23 | Bristol-Myers Squibb Company | Immunomodulators |
US11857352B2 (en) | 2016-09-06 | 2024-01-02 | The Research Foundation For The State University Of New York | Positron imaging tomography imaging agent composition and method for bacterial infection |
CA3045466A1 (en) | 2016-12-01 | 2018-06-07 | Regeneron Pharmaceuticals, Inc. | Radiolabeled anti-pd-l1 antibodies for immuno-pet imaging |
BR112019012986A2 (en) * | 2016-12-23 | 2019-12-03 | Univ Johns Hopkins | tumor and immune cell imaging based on pd-11 expression |
EA201991673A1 (en) | 2017-02-10 | 2020-01-17 | Регенерон Фармасьютикалз, Инк. | LAB3-labeled RADIOACTIVE ISOTOPE ANTIBODIES FOR IMMUNO-PET VISUALIZATION |
US11066445B2 (en) | 2017-06-23 | 2021-07-20 | Bristol-Myers Squibb Company | Immunomodulators acting as antagonists of PD-1 |
JP7304846B2 (en) | 2017-07-24 | 2023-07-07 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | ANTI-CD8 ANTIBODY AND USES THEREOF |
WO2019070643A1 (en) | 2017-10-03 | 2019-04-11 | Bristol-Myers Squibb Company | Immunomodulators |
CN110504017B (en) * | 2019-07-30 | 2022-06-10 | 哈尔滨医科大学 | Preparation and application method of tracer |
WO2021188480A1 (en) * | 2020-03-16 | 2021-09-23 | Bristol-Myers Squibb Company | Immunomodulators |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
US5374548A (en) | 1986-05-02 | 1994-12-20 | Genentech, Inc. | Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor |
MX9203291A (en) | 1985-06-26 | 1992-08-01 | Liposome Co Inc | LIPOSOMAS COUPLING METHOD. |
US5776093A (en) | 1985-07-05 | 1998-07-07 | Immunomedics, Inc. | Method for imaging and treating organs and tissues |
US5101827A (en) | 1985-07-05 | 1992-04-07 | Immunomedics, Inc. | Lymphographic and organ imaging method and kit |
US4735210A (en) | 1985-07-05 | 1988-04-05 | Immunomedics, Inc. | Lymphographic and organ imaging method and kit |
US5328679A (en) | 1988-04-01 | 1994-07-12 | Immunomedics, Inc. | Methods for technetium/rhenium labeling of proteins |
US5128119A (en) | 1989-06-12 | 1992-07-07 | Immunomedics, Inc. | Methods for technetium/rhenium labeling of f(ab1)2 fragments |
US5108921A (en) | 1989-04-03 | 1992-04-28 | Purdue Research Foundation | Method for enhanced transmembrane transport of exogenous molecules |
US5746996A (en) | 1994-06-03 | 1998-05-05 | Immunomedics, Inc. | Thiolation of peptides for radionuclide-based radiodetection and radiotherapy |
IL113610A0 (en) | 1994-06-03 | 1995-08-31 | Immunomedics Inc | A method of radiolabeling a protein, radiolabeled proteins prepared thereby and diagnostic kits containing the same |
US5869451A (en) | 1995-06-07 | 1999-02-09 | Glaxo Group Limited | Peptides and compounds that bind to a receptor |
US5753206A (en) | 1995-06-07 | 1998-05-19 | Immunomedics, Inc. | Radiometal-binding analogues of luteinizing hormone releasing hormone |
DE69737867T2 (en) | 1996-05-03 | 2007-10-18 | Immunomedics, Inc. | TARGETED COMBINATION IMMUNOTHERAPY FOR CANCER |
DE69738353T2 (en) | 1996-07-12 | 2009-09-24 | Immunomedics, Inc. | RADIOMETALL-BINDING PEPTIDE ANALOG |
US6277818B1 (en) | 1998-10-29 | 2001-08-21 | Angstrom Pharmaceuticals, Inc. | Cyclic peptide ligands that target urokinase plasminogen activator receptor |
CA2302360C (en) | 1997-09-03 | 2005-11-15 | Immunomedics, Inc. | Fluorination of proteins and peptides for f-18 positron emission tomography |
EP2141175B1 (en) | 2007-03-26 | 2016-07-27 | The University of Tokyo | Process for synthesizing cyclic peptide compound |
AU2009288289B2 (en) | 2008-08-25 | 2012-11-08 | Amplimmune, Inc. | PD-1 antagonists and methods of use thereof |
US8907053B2 (en) | 2010-06-25 | 2014-12-09 | Aurigene Discovery Technologies Limited | Immunosuppression modulating compounds |
JP5818237B2 (en) | 2010-09-09 | 2015-11-18 | 国立大学法人 東京大学 | Translational construction and search for active species of special peptide compound library containing N-methylamino acid and other special amino acids |
WO2012074130A1 (en) | 2010-12-03 | 2012-06-07 | 国立大学法人東京大学 | Peptide library production method, peptide library, and screening method |
WO2012168944A1 (en) | 2011-06-08 | 2012-12-13 | Aurigene Discovery Technologies Limited | Therapeutic compounds for immunomodulation |
WO2013010573A1 (en) | 2011-07-18 | 2013-01-24 | Universitaet Muenster | Compounds with matrix-metalloproteinase inhibitory activity |
RU2014143443A (en) | 2012-03-29 | 2016-05-20 | Ориджин Дискавери Текнолоджиз Лимитед | IMMUNOMODULATING CYCLE COMPOUNDS |
JP2013253842A (en) | 2012-06-06 | 2013-12-19 | Univ Of Tokyo | Screening method for peptide connected to target molecule depending on ph |
ES2647076T3 (en) | 2012-06-06 | 2017-12-19 | Polyphor Ag | Beta fork peptidomimetics |
EP3633377A1 (en) | 2013-03-15 | 2020-04-08 | F. Hoffmann-La Roche AG | Biomarkers and methods of treating pd-1 and pd-l1 related conditions |
US9308236B2 (en) | 2013-03-15 | 2016-04-12 | Bristol-Myers Squibb Company | Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions |
CN105813640A (en) | 2013-09-06 | 2016-07-27 | 奥瑞基尼探索技术有限公司 | Cyclic peptidomimetic compounds as immunomodulators |
WO2015044900A1 (en) | 2013-09-27 | 2015-04-02 | Aurigene Discovery Technologies Limited | Therapeutic immunomodulating compounds |
EP3191113B1 (en) | 2014-09-11 | 2019-11-06 | Bristol-Myers Squibb Company | Macrocyclic inhibitors of the pd-1/pd-l1 and cd80 (b7-1)/pd-l1 protein/protein interactions |
US9732119B2 (en) | 2014-10-10 | 2017-08-15 | Bristol-Myers Squibb Company | Immunomodulators |
US9856292B2 (en) * | 2014-11-14 | 2018-01-02 | Bristol-Myers Squibb Company | Immunomodulators |
ES2941895T3 (en) | 2014-11-25 | 2023-05-26 | Bristol Myers Squibb Co | Methods and Compositions for 18F Radiolabeling of the Fibronectin Type (III) Domain |
US10406251B2 (en) * | 2014-11-25 | 2019-09-10 | Bristol-Myers Squibb Company | PD-L1 binding polypeptides for imaging |
US9861680B2 (en) | 2014-12-18 | 2018-01-09 | Bristol-Myers Squibb Company | Immunomodulators |
US9944678B2 (en) | 2014-12-19 | 2018-04-17 | Bristol-Myers Squibb Company | Immunomodulators |
US20160222060A1 (en) | 2015-02-04 | 2016-08-04 | Bristol-Myers Squibb Company | Immunomodulators |
US9809625B2 (en) | 2015-03-18 | 2017-11-07 | Bristol-Myers Squibb Company | Immunomodulators |
US10143746B2 (en) | 2016-03-04 | 2018-12-04 | Bristol-Myers Squibb Company | Immunomodulators |
US10358463B2 (en) | 2016-04-05 | 2019-07-23 | Bristol-Myers Squibb Company | Immunomodulators |
WO2017210335A1 (en) | 2016-06-01 | 2017-12-07 | Bristol-Myers Squibb Company | Imaging methods using 18f-radiolabeled biologics |
ES2910832T3 (en) | 2016-11-07 | 2022-05-13 | Bristol Myers Squibb Co | Immunomodulators |
US11066445B2 (en) | 2017-06-23 | 2021-07-20 | Bristol-Myers Squibb Company | Immunomodulators acting as antagonists of PD-1 |
WO2019070643A1 (en) | 2017-10-03 | 2019-04-11 | Bristol-Myers Squibb Company | Immunomodulators |
-
2017
- 2017-05-17 ES ES17728696T patent/ES2864091T3/en active Active
- 2017-05-17 JP JP2018560588A patent/JP6953444B2/en active Active
- 2017-05-17 BR BR112018073642-2A patent/BR112018073642A2/en unknown
- 2017-05-17 AU AU2017268291A patent/AU2017268291B2/en active Active
- 2017-05-17 CN CN201780042462.1A patent/CN109414514B/en active Active
- 2017-05-17 KR KR1020187036396A patent/KR102378288B1/en active IP Right Grant
- 2017-05-17 WO PCT/US2017/033004 patent/WO2017201111A1/en unknown
- 2017-05-17 DK DK17728696.0T patent/DK3458111T3/en active
- 2017-05-17 EP EP17728696.0A patent/EP3458111B1/en active Active
- 2017-05-17 EA EA201892635A patent/EA038019B1/en unknown
- 2017-05-17 HU HUE17728696A patent/HUE054306T2/en unknown
- 2017-05-17 US US16/098,765 patent/US11103605B2/en active Active
- 2017-05-17 MA MA053402A patent/MA53402A/en unknown
- 2017-05-17 SI SI201730690T patent/SI3458111T1/en unknown
- 2017-05-17 CA CA3024844A patent/CA3024844A1/en active Pending
- 2017-05-17 RS RS20210499A patent/RS61742B1/en unknown
- 2017-05-17 MX MX2018014028A patent/MX2018014028A/en unknown
- 2017-05-17 LT LTEP17728696.0T patent/LT3458111T/en unknown
- 2017-05-17 PL PL17728696T patent/PL3458111T3/en unknown
- 2017-05-17 PT PT177286960T patent/PT3458111T/en unknown
- 2017-05-17 EP EP21152813.8A patent/EP3827849A1/en active Pending
- 2017-05-17 SG SG11201810177VA patent/SG11201810177VA/en unknown
-
2018
- 2018-11-12 IL IL262962A patent/IL262962B/en active IP Right Grant
-
2021
- 2021-04-23 HR HRP20210644TT patent/HRP20210644T8/en unknown
- 2021-04-29 CY CY20211100375T patent/CY1124241T1/en unknown
- 2021-08-26 US US17/412,612 patent/US20210386876A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112018073642A2 (en) | toe imaging immunomodulators | |
BR112017010414A2 (en) | methods and compositions for 18f radiolabeling of biological substances | |
BR112017009497A2 (en) | aadc polynucleotides for the treatment of parkinson's disease | |
SV2017005426A (en) | DERIVATIVES OF PHENILTRIAZOL REPLACED WITH HYDROXIALQUIL AND ITS USES | |
CL2015000717A1 (en) | Compounds derived from bicyclic pyridinones and their salts; pharmaceutical composition that includes them; and its use for the treatment of neurodegeneration and psychiatric disorders, which include Alzheimer's disease or Niemann-pick type C disease. | |
BR112016018062A8 (en) | therapeutic compounds, pharmaceutical composition and uses | |
CR20160485A (en) | CYCLOPROPANAMINE COMPOUND AND ITS USES | |
CR20160537A (en) | 3-QUINASA DELTA PHOSFOINOSYTI INHIBITOR FOR MEDICAL USE | |
CL2014000806A1 (en) | Compounds derived from 1-arylcarbonyl-4-oxy-piperidino; pharmaceutical composition that includes them; Use for the prevention or treatment of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease or multiple sclerosis. | |
BR112016025819A2 (en) | adeno-associated virus vectors for the treatment of lysosomal deposition diseases | |
CL2014001838A1 (en) | Compounds derived from fluormethyl-5,6-dihydro-4h- [1,3] oxazin-2-ylamine, as bace1 inhibitors; its process of obtaining; pharmaceutical composition that contains them; and its use for the therapeutic and / or prophylactic treatment of Alzheimer's disease, amyotrophic lateral sclerosis, cancer, cardiovascular diseases and gastrointestinal diseases, among others. | |
BR112018072545A2 (en) | arginase inhibitors and their therapeutic applications | |
BR112019009172A2 (en) | formulations for radiotherapy and diagnostic imaging. | |
BR112016016274A2 (en) | BLOOD-BRAIN BARRIER BRIDGE | |
CL2015000615A1 (en) | Compounds derived from 4-amino-quinolines, rip2 kinase inhibitors; pharmaceutical composition that includes them; use for the treatment of diseases such as crohn's disease, ulcerative colitis or blau syndrome. | |
CL2018000597A1 (en) | Methods to treat inflammatory diseases | |
GT201700058A (en) | 1-ALKYL-6-OXO-1,6-DIHYDROPYRIDIN-3-ILO COMPOUNDS AND USES THEREOF | |
UY35276A (en) | New compounds that inhibit the activity of Lp-PLA2 | |
BR112017012381A2 (en) | immunotherapy for angiogenic disease | |
BR112015019873A2 (en) | macrocyclic lrrk2 kinase inhibitors | |
BR112016017620A2 (en) | STEROIDAL COMPOUND FOR USE IN THE TREATMENT OF HEPATIC ENCEPHALOPATHY | |
BR112017011543A2 (en) | cd44v6-derived cyclic peptides for the treatment of cancers and angiogenesis-related diseases | |
IL266778A (en) | Combined assay for the differential diagnosis of the alzheimer's disease | |
BR112017002675A2 (en) | methods for improving myocardial performance in fontan patients using udenafil compositions | |
BR112017003334A2 (en) | disintegrin variants and pharmaceutical uses of these |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |